本页面由Tiger Trade Technology Pte. Ltd.提供服务

Janux Therapeutics, Inc.

18.89
+0.21001.12%
盘后18.70-0.1900-1.01%19:52 EDT
成交量:52.40万
成交额:982.79万
市值:11.55亿
市盈率:-11.50
高:18.95
开:18.59
低:18.33
收:18.68
52周最高:35.34
52周最低:12.12
股本:6,113.68万
流通股本:4,981.62万
量比:0.52
换手率:1.05%
股息:- -
股息率:- -
每股收益(TTM):-1.6429
每股收益(LYR):-1.8336
净资产收益率:-10.70%
总资产收益率:-8.80%
市净率:1.24
市盈率(LYR):-10.30

数据加载中...

2026/08/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/07/29

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/06/24

重要事件披露

Form 8-K - Current report
2026/06/12

重要事件披露

Form 8-K - Current report
2026/06/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/12

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/07

重要事件披露

Form 8-K - Current report
2026/05/06

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/29

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/29

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/28

重要事件披露

Form 8-K - Current report
2026/04/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/26

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]